Abstract
After the significant decision by the Federal Council of Medicine to veto the prescription of testosterone by doctors for aesthetic purposes, the major discussion revolves around the competence of users and other healthcare professionals regarding the monitoring of side effects that impact the patients' quality of life. This is because these individuals may potentially seek other ways to use the anabolic agent. In this case report, we present the case of a young, healthy patient without previous comorbidities, who exhibited significant ophthalmological changes during a routine check-up, consistent with systemic arterial hypertension, which had not been identified during their follow-up consultations with an endocrinologist.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
